Navigation Links
OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment

Madison, Wis. -- OpGen, Inc., a provider of single-molecule DNA analysis technology, announced Thursday it has commenced an optical mapping study of a deadly type of brain tumor, known as oligodendroglioma. OpGen, based in Madison, is working with the Hermelin Brain Tumor Center
Full article >>> type of solid tumor or other forms of cancer; we intend to demonstrate this capability by conducting the first high-resolution scan of this tumor, Schwartz said.

OpGen and Schwartz have been working with a group of statisticians and mathematicians, which include Michael Waterman, professor of biological sciences and ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/23/04


Related biology technology :

1. OpGen layoffs precede another funding round
2. OpGen forges agreement with Japanese importer
3. OpGen completes $5 million investment round
4. OpGen recruits CEO to further gene-mapping business
5. OpGen adds Thomas Pyle and James Ogle to board of directors
6. OpGen Creates Map of Worlds Most Lethal Fungus
7. OpGen Database Helps to Reduce Bioterrorist Threat
8. Chemical-petroleum executive joins Virent Energy board
9. Schneider National exec joins TrafficCast board
10. Doyle joins governors in support of stem cell bill
11. Genomics researcher Hood joins NimbleGen board
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):